1 |
0.15mg kpg-818 dose |
- |
- |
- |
- |
049 [1] 49 💬 |
2 |
0.6mg kpg-818 dose |
- |
- |
- |
- |
049 [1] 49 💬 |
3 |
1 mg/kg cnto 136 |
- |
- |
- |
- |
049 [1] 49 💬 |
4 |
10 mg/kg cnto 136 |
- |
- |
- |
- |
049 [1] 49 💬 |
5 |
2-deoxy-2 [f-18] fluoro-2-d-glucose |
D-glucose |
[1] D00009 D00009 💬 |
- |
- |
049 [1] 49 💬 |
6 |
2mg kpg-818 dose |
- |
- |
- |
- |
049 [1] 49 💬 |
7 |
4 mg/kg cnto 136 |
- |
- |
- |
- |
049 [1] 49 💬 |
8 |
81mg aspirin |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
049 [1] 49 💬 |
9 |
A-623 |
- |
- |
- |
- |
049 [1] 49 💬 |
10 |
Abatacept |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
11 |
Abbv-105 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
12 |
Abetimus |
Abetimus |
- |
- |
- |
049 [1] 49 💬 |
13 |
Abetimus sodium |
Abetimus |
- |
- |
- |
049 [1] 49 💬 |
14 |
Abetimus sodium (ljp 394) |
Abetimus |
- |
- |
- |
049 [1] 49 💬 |
15 |
Abr-215757 |
- |
- |
- |
- |
049 [2] 49, 51 💬 |
16 |
Abt-199 |
- |
- |
- |
- |
049 [1] 49 💬 |
17 |
Abt-494 |
- |
- |
- |
- |
041 [6] 41, 46, 49, 96, 97, 271 💬 |
18 |
Ac0058ta |
- |
- |
- |
- |
049 [1] 49 💬 |
19 |
Acetaminophen |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 [14] 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
20 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
21 |
Acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [16] 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
22 |
Acido micofenolico |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
049 [1] 49 💬 |
23 |
Acm |
- |
- |
- |
- |
049 [1] 49 💬 |
24 |
Act-334441 |
- |
- |
- |
- |
049 [1] 49 💬 |
25 |
Acthar |
- |
- |
- |
- |
002 [9] 2 , 13, 14, 46, 49, 50, 66, 84, 222 💬 |
26 |
Acthar gel |
- |
- |
- |
- |
013 [6] 13, 46, 49, 50, 84, 222 💬 |
27 |
Acthar high dose (80 u) |
- |
- |
- |
- |
049 [1] 49 💬 |
28 |
Acthar low dose (40 u) |
- |
- |
- |
- |
049 [1] 49 💬 |
29 |
Ags-009 |
- |
- |
- |
- |
049 [1] 49 💬 |
30 |
Aidsvax® b/e |
- |
- |
- |
- |
049 [1] 49 💬 |
31 |
Akbm-3031 |
- |
- |
- |
- |
049 [1] 49 💬 |
32 |
Aldesleuchina |
- |
- |
- |
- |
049 [1] 49 💬 |
33 |
Aldesleukin |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 [4] 49, 65, 96, 97 💬 |
34 |
Alfacalcidol |
Alfacalcidol |
[1] D01518 D01518 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
041 [6] 41, 46, 49, 50, 96, 235 💬 |
35 |
Alitretinoin |
Alitretinoin |
[1] D02815 D02815 💬 |
RARA [5] RARA, RARB, RXRA, RXRB, RXRG 💬 |
Acute myeloid leukemia [17] Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer |
049 [1] 49 💬 |
36 |
Allogeneic bone marrow transplant |
- |
- |
- |
- |
049 [1] 49 💬 |
37 |
Allogeneic mesenchymal stromal cells derived from the umbilical cord |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
049 [1] 49 💬 |
38 |
Allogeneic msc (allomsc) |
- |
- |
- |
- |
049 [1] 49 💬 |
39 |
Allogeneic stem cell transplantation |
- |
- |
- |
- |
049 [2] 49, 84 💬 |
40 |
Alpha-tocopherol |
Tocopherol |
[2] D02331 D02331, D02332 D02332 💬 |
- |
- |
049 [2] 49, 206 💬 |
41 |
Alx-0061 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
42 |
Alx-0061 150 mg/ml |
- |
- |
- |
- |
049 [1] 49 💬 |
43 |
Amg 557 |
- |
- |
- |
- |
049 [1] 49 💬 |
44 |
Amg 570 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
45 |
Amg 592 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
46 |
Amg 623 |
- |
- |
- |
- |
049 [1] 49 💬 |
47 |
Amg 811 |
- |
- |
- |
- |
049 [1] 49 💬 |
48 |
Amg592 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
49 |
Amg811 |
- |
- |
- |
- |
049 [1] 49 💬 |
50 |
Anakinra |
Anakinra |
[1] D02934 D02934 💬 |
IL1R1 [2] IL1R1, IL1R2 💬 |
Amoebiasis [15] Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 [17] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬 |
51 |
Anifrolumab |
Anifrolumab |
[1] D11082 D11082 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
046 [2] 46, 49 💬 |
52 |
Anifrolumab 1000 mg |
Anifrolumab |
[1] D11082 D11082 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
049 [1] 49 💬 |
53 |
Anifrolumab 300 mg |
Anifrolumab |
[1] D11082 D11082 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
049 [1] 49 💬 |
54 |
Anti baff (b cell activating factor) |
- |
- |
- |
- |
049 [1] 49 💬 |
55 |
Anti lp40 antibody, subclass igg4 |
- |
- |
- |
- |
049 [1] 49 💬 |
56 |
Anti lp40 anticuerpo, subclase igg4 |
- |
- |
- |
- |
049 [1] 49 💬 |
57 |
Anti-blood dendritic cell antigen 2 |
- |
- |
- |
- |
049 [1] 49 💬 |
58 |
Anti-cd19-car-t cells |
- |
- |
- |
- |
049 [1] 49 💬 |
59 |
Anti-cd20 b cell depletion with truxima |
- |
- |
- |
- |
049 [1] 49 💬 |
60 |
Anti-cd28dab |
- |
- |
- |
- |
049 [3] 49, 53, 160 💬 |
61 |
Anti-macrophage migration inhibitory factor (anti-mif) antibody |
- |
- |
- |
- |
049 [1] 49 💬 |
62 |
Anti-pandemic h1n1 influenza vaccine |
- |
- |
- |
- |
046 [5] 46, 49, 50, 51, 53 💬 |
63 |
Anti-thymocyte globulin |
- |
- |
- |
- |
011 [18] 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
64 |
Asf-1096 cream 0.25% |
- |
- |
- |
- |
049 [1] 49 💬 |
65 |
Asf-1096 cream 0.5% |
- |
- |
- |
- |
049 [1] 49 💬 |
66 |
Asf-1096 cream 1.0% |
- |
- |
- |
- |
049 [1] 49 💬 |
67 |
Aspirin |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [11] 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬 |
68 |
Aspirin and meloxicam |
Acetylsalicylic acid |
[2] D00109 D00109, D00969 D00969 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
049 [1] 49 💬 |
69 |
Atacicept |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [4] 13, 46, 49, 66 💬 |
70 |
Atacicept 150 mg |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [2] 13, 49 💬 |
71 |
Atacicept 75 mg |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [3] 13, 49, 66 💬 |
72 |
Atacicept 75 milligram (mg) |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
73 |
Atorvastatin |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
74 |
Autologous ebv specific ctl infusion |
- |
- |
- |
- |
049 [1] 49 💬 |
75 |
Aviptadil |
Aviptadil |
- |
- |
- |
049 [4] 49, 51, 85, 86 💬 |
76 |
Azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
006 [20] 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
77 |
Baricitinib |
Baricitinib |
[1] D10308 D10308 💬 |
JAK1 [2] JAK1, JAK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [33] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
041 [9] 41, 46, 49, 50, 93, 107, 265, 268, 325 💬 |
78 |
Behavioral: heart health educational program |
- |
- |
- |
- |
049 [1] 49 💬 |
79 |
Behavioral: questionnaires |
- |
- |
- |
- |
028 [2] 28, 49 💬 |
80 |
Belimumab |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 [10] 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬 |
81 |
Belimumab 1 mg/kg |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 [2] 46, 49 💬 |
82 |
Belimumab 10 mg/kg |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
043 [3] 43, 46, 49 💬 |
83 |
Belimumab 10 mg/kg plus standard therapy |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
84 |
Belimumab 100 mg sc |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
85 |
Belimumab 10mg/kg |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
86 |
Belimumab 200 mg sc |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
87 |
Belimumab 200 mg/ml |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
88 |
Belimumab 4 mg/kg |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 [2] 46, 49 💬 |
89 |
Belimumab for iv |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
90 |
Belimumab for sc |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
91 |
Belimumab injection |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
92 |
Belimumab injection [benlysta] |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
93 |
Belimumab or benlysta |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
94 |
Belimumab plus early vaccination |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
95 |
Belimumab plus late vaccination |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
96 |
Benazepril |
Benazepril |
[2] D00620 D00620, D07499 D07499 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
049 [4] 49, 57, 218, 224 💬 |
97 |
Benazepril pill |
Benazepril |
[2] D00620 D00620, D07499 D07499 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
049 [1] 49 💬 |
98 |
Benlysta |
- |
- |
- |
- |
043 [5] 43, 49, 53, 66, 222 💬 |
99 |
Benlysta (belimumab) |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 [4] 11, 49, 53, 222 💬 |
100 |
Benlysta 400 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
043 [2] 43, 49 💬 |
101 |
Benlysta 400 mg powder for concentrate for solution for infusions |
- |
- |
- |
- |
049 [1] 49 💬 |
102 |
Benlysta? (belimumab) |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
103 |
Benlysta® |
- |
- |
- |
- |
049 [2] 49, 222 💬 |
104 |
Benlysta™ (belimumab) |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
105 |
Bi 705564 |
- |
- |
- |
- |
049 [1] 49 💬 |
106 |
Biib059 |
- |
- |
- |
- |
049 [1] 49 💬 |
107 |
Blisibimod |
Blisibimod |
[1] D10311 D10311 💬 |
- |
- |
043 [5] 43, 44, 49, 63, 66 💬 |
108 |
Blood sample |
- |
- |
- |
- |
008 [13] 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
109 |
Bms-188667 |
- |
- |
- |
- |
046 [8] 46, 49, 53, 65, 96, 97, 222, 271 💬 |
110 |
Bms-931699 |
Lulizumab pegol |
- |
- |
- |
049 [3] 49, 53, 160 💬 |
111 |
Bms-986165 |
- |
- |
- |
- |
049 [3] 49, 96, 97 💬 |
112 |
Bms-986165 capsule |
- |
- |
- |
- |
049 [1] 49 💬 |
113 |
Bms-986165 tablet |
- |
- |
- |
- |
049 [1] 49 💬 |
114 |
Bms-986195 |
Branebrutinib |
[1] D11478 D11478 💬 |
BTK [1] BTK 💬 |
B cell receptor signaling pathway [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
046 [3] 46, 49, 53 💬 |
115 |
Bms986195 |
- |
- |
- |
- |
046 [3] 46, 49, 53 💬 |
116 |
Bortezomib |
Bortezomib |
[1] D03150 D03150 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
117 |
Bos161721 |
- |
- |
- |
- |
049 [1] 49 💬 |
118 |
Br-dim |
- |
- |
- |
- |
049 [1] 49 💬 |
119 |
Branebrutinib |
Branebrutinib |
[1] D11478 D11478 💬 |
BTK [1] BTK 💬 |
B cell receptor signaling pathway [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
046 [3] 46, 49, 53 💬 |
120 |
Brentuximab |
Brentuximab vedotin |
[1] D09587 D09587 💬 |
TNFRSF8 [10] TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [11] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
049 [2] 49, 51 💬 |
121 |
Brentuximab vedotin |
Brentuximab vedotin |
[1] D09587 D09587 💬 |
TNFRSF8 [10] TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [11] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
049 [2] 49, 51 💬 |
122 |
Bt063 |
- |
- |
- |
- |
049 [1] 49 💬 |
123 |
Busulfan |
Busulfan |
[1] D00248 D00248 💬 |
- |
- |
019 [13] 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬 |
124 |
Calcitriol |
Calcitriol |
[1] D00129 D00129 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
037 [8] 37, 46, 49, 66, 96, 158, 235, 326 💬 |
125 |
Calcium |
Calcium |
- |
- |
- |
006 [27] 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
126 |
Campath |
- |
- |
- |
- |
019 [12] 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬 |
127 |
Cc |
- |
- |
- |
- |
013 [13] 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
128 |
Cc-220 |
CC-220 |
- |
- |
- |
049 [2] 49, 84 💬 |
129 |
Cdp3194 |
- |
- |
- |
- |
049 [1] 49 💬 |
130 |
Cdp7657 |
- |
- |
- |
- |
049 [1] 49 💬 |
131 |
Cellcept |
- |
- |
- |
- |
011 [5] 11, 13, 42, 43, 49 💬 |
132 |
Cenerimod |
Cenerimod |
[1] D11283 D11283 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
049 [1] 49 💬 |
133 |
Cenerimod 0.5 mg |
Cenerimod |
[1] D11283 D11283 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
049 [1] 49 💬 |
134 |
Cenerimod 1 mg |
Cenerimod |
[1] D11283 D11283 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
049 [1] 49 💬 |
135 |
Cenerimod 2 mg |
Cenerimod |
[1] D11283 D11283 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
049 [1] 49 💬 |
136 |
Cenerimod 4 mg |
Cenerimod |
[1] D11283 D11283 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
049 [1] 49 💬 |
137 |
Cep-33457 |
- |
- |
- |
- |
049 [1] 49 💬 |
138 |
Cervarix |
- |
- |
- |
- |
049 [2] 49, 50 💬 |
139 |
Cervarix suspensie voor injectie |
- |
- |
- |
- |
049 [2] 49, 50 💬 |
140 |
Cfz533 |
- |
- |
- |
- |
011 [4] 11, 46, 49, 53 💬 |
141 |
Chloroquine |
Chloroquine |
[3] D02125 D02125, D02366 D02366, D03469 D03469 💬 |
- |
- |
046 [3] 46, 49, 95 💬 |
142 |
Cholecalciferol |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [9] 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
143 |
Cholecalciferol and c. xanthorrhiza |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
049 [1] 49 💬 |
144 |
Ciclosporin |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
026 [13] 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269 💬 |
145 |
Ciclosporina |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
049 [3] 49, 97, 228 💬 |
146 |
Clofarabine |
Clofarabine |
[1] D03546 D03546 💬 |
POLA1 [3] POLA1, POLA2, RRM1 💬 |
DNA replication [6] DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
019 [9] 19, 20, 40, 46, 49, 60, 96, 234, 326 💬 |
147 |
Clopidogrel |
Clopidogrel |
[4] D00769 D00769, D07729 D07729, D10823 D10823, D10824 D10824 💬 |
P2RY12 [1] P2RY12 💬 |
Platelet activation [1] Platelet activation |
049 [2] 49, 86 💬 |
148 |
Cnto1275 |
- |
- |
- |
- |
046 [6] 46, 49, 84, 93, 96, 97 💬 |
149 |
Combination product: belimumab |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
150 |
Conjugated equine estrogens |
Conjugated estrogens |
[2] D04070 D04070, D05987 D05987 💬 |
- |
- |
049 [1] 49 💬 |
151 |
Conjugated equine estrogens 0.625 mg/d + mpa 5 mg/d/10d |
Conjugated estrogens |
[2] D04070 D04070, D05987 D05987 💬 |
- |
- |
049 [1] 49 💬 |
152 |
Continuation of azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
049 [1] 49 💬 |
153 |
Corn starch |
Starch, corn |
[1] D05297 D05297 💬 |
- |
- |
049 [1] 49 💬 |
154 |
Corticosteroids |
- |
- |
- |
- |
041 [10] 41, 46, 49, 64, 97, 107, 164, 220, 296, 300 💬 |
155 |
Corticosteroids (prednisone or prednisolone) |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
156 |
Creatine |
Creatine |
- |
- |
- |
001 [12] 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
157 |
Crestor |
- |
- |
- |
- |
049 [3] 49, 79, 299 💬 |
158 |
Csa |
- |
- |
- |
- |
019 [8] 19, 49, 50, 53, 60, 63, 222, 228 💬 |
159 |
Csm allogéniques issues de cordons ombilicaux ( mti-pp) |
- |
- |
- |
- |
049 [1] 49 💬 |
160 |
Ctla4-igg4m (rg2077) |
- |
- |
- |
- |
049 [1] 49 💬 |
161 |
Ctla4ig |
- |
- |
- |
- |
046 [4] 46, 49, 96, 271 💬 |
162 |
Cumulative corticosteroid exposure |
- |
- |
- |
- |
049 [1] 49 💬 |
163 |
Curcumin |
Curcumin |
- |
- |
- |
002 [11] 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
164 |
Curcumin supplement |
Curcumin |
- |
- |
- |
049 [1] 49 💬 |
165 |
Cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
011 [44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
166 |
Cyclophosphamide-prednisone-azathioprine |
Azathioprine |
[5] D00238 D00238, D00287 D00287, D00473 D00473, D03033 D03033, D07760 D07760 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
167 |
Cyclosporin |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 [17] 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 |
168 |
Cyclosporin a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 [11] 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 💬 |
169 |
Cyclosporine |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 [35] 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
170 |
Cyclosporine a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 [10] 19, 20, 36, 49, 50, 53, 58, 60, 234, 283 💬 |
171 |
Cymbalta |
- |
- |
- |
- |
006 [3] 6 , 13, 49 💬 |
172 |
Cytarabine |
Cytarabine |
[3] D00168 D00168, D03046 D03046, D03637 D03637 💬 |
- |
- |
011 [6] 11, 13, 14, 25, 49, 60 💬 |
173 |
D-glucose |
D-glucose |
[1] D00009 D00009 💬 |
- |
- |
049 [3] 49, 86, 88 💬 |
174 |
Dapagliflozin |
Dapagliflozin |
[1] D08897 D08897 💬 |
- |
- |
049 [2] 49, 222 💬 |
175 |
Dapirolizumab pegol |
Dapirolizumab pegol |
- |
- |
- |
013 [2] 13, 49 💬 |
176 |
Dapirolizumab pegol (dzp) |
Dapirolizumab pegol |
- |
- |
- |
049 [1] 49 💬 |
177 |
Dehydroepiandrosterone |
Prasterone |
[1] D08409 D08409 💬 |
AR [3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 [5] 49, 53, 83, 96, 113 💬 |
178 |
Dehydroepiandrosterone (dhea) |
Prasterone |
[1] D08409 D08409 💬 |
AR [3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 [1] 49 💬 |
179 |
Deltacortene*20cpr 5mg |
- |
- |
- |
- |
049 [3] 49, 97, 113 💬 |
180 |
Device: belimumab autoinjector |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
181 |
Device: bone densitometry |
- |
- |
- |
- |
049 [1] 49 💬 |
182 |
Device: doppler ultrasound |
- |
- |
- |
- |
049 [1] 49 💬 |
183 |
Device: fan beam ct scan |
- |
- |
- |
- |
049 [1] 49 💬 |
184 |
Device: flash glucose monitoring system |
Dextrose, unspecified form |
- |
- |
- |
049 [1] 49 💬 |
185 |
Device: flow-mediated dilation of the brachial artery |
- |
- |
- |
- |
049 [1] 49 💬 |
186 |
Dha |
- |
- |
- |
- |
006 [8] 6 , 46, 48, 49, 94, 113, 299, 301 💬 |
187 |
Dhea |
Prasterone |
[1] D08409 D08409 💬 |
AR [3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 [3] 49, 86, 96 💬 |
188 |
Dihydroartemisinin |
Artenimol |
[1] D07362 D07362 💬 |
- |
- |
049 [1] 49 💬 |
189 |
Dihydroartemisinin tablet |
Artenimol |
[1] D07362 D07362 💬 |
- |
- |
049 [1] 49 💬 |
190 |
Dimethylfumarat |
- |
- |
- |
- |
049 [1] 49 💬 |
191 |
Diphenhydramine |
Diphenhydramine |
[6] D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 [8] 11, 49, 51, 70, 86, 96, 222, 256 💬 |
192 |
Dipyridamole |
Dipyridamole |
[1] D00302 D00302 💬 |
PDE4A [2] PDE4A, PDE5A 💬 |
Metabolic pathways [6] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [5] 46, 49, 51, 66, 224 💬 |
193 |
Docosahexaenoic acid |
Doconexent |
- |
- |
- |
006 [7] 6 , 49, 90, 94, 240, 299, 301 💬 |
194 |
Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
195 |
Dzp |
- |
- |
- |
- |
049 [1] 49 💬 |
196 |
Edratide |
Edratide |
[1] D03957 D03957 💬 |
- |
- |
049 [1] 49 💬 |
197 |
Edratide acetate |
Acetate |
[1] D03957 D03957 💬 |
- |
- |
049 [1] 49 💬 |
198 |
Eicosapentaenoic acid |
Icosapent |
[1] D08061 D08061 💬 |
- |
- |
049 [5] 49, 96, 97, 296, 297 💬 |
199 |
Elsubrutinib |
- |
- |
- |
- |
049 [1] 49 💬 |
200 |
Enteric-coated mycophenolate sodium |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
049 [1] 49 💬 |
201 |
Epa |
- |
- |
- |
- |
008 [6] 8 , 46, 48, 49, 113, 301 💬 |
202 |
Epa and dha supplementation |
- |
- |
- |
- |
048 [2] 48, 49 💬 |
203 |
Epatuzumab |
- |
- |
- |
- |
049 [1] 49 💬 |
204 |
Epratuzumab |
Epratuzumab |
[1] D04036 D04036 💬 |
CD22 [1] CD22 💬 |
B cell receptor signaling pathway [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 [1] 49 💬 |
205 |
Epratuzumab 100 mg |
Epratuzumab |
[1] D04036 D04036 💬 |
CD22 [1] CD22 💬 |
B cell receptor signaling pathway [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 [1] 49 💬 |
206 |
Epratuzumab 1200 mg |
Epratuzumab |
[1] D04036 D04036 💬 |
CD22 [1] CD22 💬 |
B cell receptor signaling pathway [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 [1] 49 💬 |
207 |
Epratuzumab 400 mg |
Epratuzumab |
[1] D04036 D04036 💬 |
CD22 [1] CD22 💬 |
B cell receptor signaling pathway [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 [1] 49 💬 |
208 |
Epratuzumab 600 mg |
Epratuzumab |
[1] D04036 D04036 💬 |
CD22 [1] CD22 💬 |
B cell receptor signaling pathway [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 [1] 49 💬 |
209 |
Epratuzumab iv |
Epratuzumab |
[1] D04036 D04036 💬 |
CD22 [1] CD22 💬 |
B cell receptor signaling pathway [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 [1] 49 💬 |
210 |
Epratuzumab sc |
Epratuzumab |
[1] D04036 D04036 💬 |
CD22 [1] CD22 💬 |
B cell receptor signaling pathway [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 [1] 49 💬 |
211 |
Erl080a |
- |
- |
- |
- |
049 [1] 49 💬 |
212 |
Estradiol |
Estradiol |
[8] D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 [5] 13, 46, 49, 226, 299 💬 |
213 |
Ethinyl estradiol |
Estradiol |
[9] D00105 D00105, D00554 D00554, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
046 [3] 46, 49, 299 💬 |
214 |
Ethylhydrogenfumarat, calciumsalz |
- |
- |
- |
- |
049 [1] 49 💬 |
215 |
Ethylhydrogenfumarat, magnesiumsalz |
- |
- |
- |
- |
049 [1] 49 💬 |
216 |
Ethylhydrogenfumarat, zinksalz |
- |
- |
- |
- |
049 [1] 49 💬 |
217 |
Evobrutinib |
Evobrutinib |
- |
- |
- |
013 [3] 13, 46, 49 💬 |
218 |
Extended release dipyridamole 200mg/aspirin 25mg |
Acetylsalicylic acid |
[2] D00109 D00109, D00302 D00302 💬 |
PDE4A [4] PDE4A, PDE5A, PTGS1, PTGS2 💬 |
Alzheimer disease [28] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Purine metabolism, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 [1] 49 💬 |
219 |
Ezetimibe |
Ezetimibe |
[1] D01966 D01966 💬 |
NPC1L1 [1] NPC1L1 💬 |
Fat digestion and absorption [1] Fat digestion and absorption |
049 [4] 49, 79, 93, 260 💬 |
220 |
Ezetimibe+simvastatin drug combination |
Ezetimibe |
[2] D00434 D00434, D01966 D01966 💬 |
HMGCR [2] HMGCR, NPC1L1 💬 |
AMPK signaling pathway [5] AMPK signaling pathway, Bile secretion, Fat digestion and absorption, Metabolic pathways, Terpenoid backbone biosynthesis |
049 [1] 49 💬 |
221 |
Faslodex |
- |
- |
- |
- |
049 [1] 49 💬 |
222 |
Filgrastim |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [27] 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
223 |
Fish oil |
Fish oil |
- |
- |
- |
013 [7] 13, 46, 49, 66, 96, 260, 299 💬 |
224 |
Fludarabine |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [17] 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
225 |
Fludarabine phosphate |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
028 [11] 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
226 |
Fluzone |
- |
- |
- |
- |
021 [2] 21, 49 💬 |
227 |
Focetria (monovalent mf59-adjuvanted vaccine) |
- |
- |
- |
- |
046 [3] 46, 49, 271 💬 |
228 |
Folate |
Folic acid |
[1] D00070 D00070 💬 |
- |
- |
013 [3] 13, 46, 49 💬 |
229 |
Folatescan (technetium tc 99mec20) |
- |
- |
- |
- |
013 [4] 13, 46, 49, 96 💬 |
230 |
Folic acid |
Folic acid |
[1] D00070 D00070 💬 |
- |
- |
006 [4] 6 , 46, 49, 84 💬 |
231 |
Forigerimod |
Forigerimod |
[1] D09904 D09904 💬 |
- |
- |
049 [1] 49 💬 |
232 |
Fostamatinib |
Fostamatinib |
[1] D09347 D09347 💬 |
SYK [1] SYK 💬 |
B cell receptor signaling pathway [17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
046 [4] 46, 49, 61, 66 💬 |
233 |
Fostamatinib disodium (r935788) |
Fostamatinib |
[1] D09347 D09347 💬 |
SYK [1] SYK 💬 |
B cell receptor signaling pathway [17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
046 [2] 46, 49 💬 |
234 |
Fumaderm® |
- |
- |
- |
- |
049 [1] 49 💬 |
235 |
Fumaderm® initial |
- |
- |
- |
- |
049 [1] 49 💬 |
236 |
G-csf |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [16] 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
237 |
Gardasil |
- |
- |
- |
- |
049 [1] 49 💬 |
238 |
Gc+hcq |
- |
- |
- |
- |
049 [1] 49 💬 |
239 |
Gdc-0853 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
240 |
Gdc-0853 ro7010939 |
- |
- |
- |
- |
013 [3] 13, 46, 49 💬 |
241 |
Genetic: polymorphism analysis |
- |
- |
- |
- |
049 [2] 49, 60 💬 |
242 |
Gl701 |
- |
- |
- |
- |
049 [1] 49 💬 |
243 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 [15] 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
244 |
Gold |
Gold |
- |
- |
- |
002 [38] 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
245 |
Group a sle prospective study |
- |
- |
- |
- |
049 [1] 49 💬 |
246 |
Growth colony stimulating factor (g-csf) |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
049 [1] 49 💬 |
247 |
Gsk1550188 |
- |
- |
- |
- |
011 [4] 11, 49, 66, 222 💬 |
248 |
Gsk1550188 1mg/kg or 10mg/kg |
- |
- |
- |
- |
049 [1] 49 💬 |
249 |
Gsk1550188 iv |
- |
- |
- |
- |
049 [1] 49 💬 |
250 |
Gsk1550188 sc |
- |
- |
- |
- |
049 [1] 49 💬 |
251 |
Gsk2586184 |
- |
- |
- |
- |
049 [1] 49 💬 |
252 |
Gsk2586184 100 mg |
- |
- |
- |
- |
049 [1] 49 💬 |
253 |
Gsk2586184 200 mg |
- |
- |
- |
- |
049 [1] 49 💬 |
254 |
Gsk2586184 400 mg |
- |
- |
- |
- |
049 [1] 49 💬 |
255 |
Gsk2586184 50 mg |
- |
- |
- |
- |
049 [1] 49 💬 |
256 |
Gsk2586184 800mg single and repeat dose |
- |
- |
- |
- |
049 [1] 49 💬 |
257 |
Gsk2586184 new formulation |
- |
- |
- |
- |
049 [1] 49 💬 |
258 |
Gsk2586184 standard formulation |
- |
- |
- |
- |
049 [1] 49 💬 |
259 |
H.p. acthar gel |
- |
- |
- |
- |
046 [5] 46, 49, 50, 84, 222 💬 |
260 |
Hcq |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
261 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 [12] 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
262 |
Hgs1006 |
- |
- |
- |
- |
049 [1] 49 💬 |
263 |
Hgs1006, lymphostat-b, monoclonal anti-blys, lsb, benlysta |
- |
- |
- |
- |
049 [2] 49, 53 💬 |
264 |
High dietary sodium |
- |
- |
- |
- |
049 [1] 49 💬 |
265 |
High dose mesenchymal stem cells (mscs) |
- |
- |
- |
- |
049 [1] 49 💬 |
266 |
Hiomega-3 supplement of naturalis® company - |
- |
- |
- |
- |
049 [1] 49 💬 |
267 |
Hll2 |
- |
- |
- |
- |
049 [1] 49 💬 |
268 |
Hll2 (epratuzumab) |
Epratuzumab |
[1] D04036 D04036 💬 |
CD22 [1] CD22 💬 |
B cell receptor signaling pathway [3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage |
049 [1] 49 💬 |
269 |
Hll2 (trivial name or chemical description) |
- |
- |
- |
- |
049 [1] 49 💬 |
270 |
Hll2,immu-103 |
- |
- |
- |
- |
049 [1] 49 💬 |
271 |
Hpv prophylactic vaccine gardasil |
- |
- |
- |
- |
049 [1] 49 💬 |
272 |
Hril-2 active |
- |
- |
- |
- |
046 [3] 46, 49, 53 💬 |
273 |
Human papillomavirus vaccination (gardasil) |
- |
- |
- |
- |
049 [1] 49 💬 |
274 |
Human umbilical cord derived msc transplantation for sle |
- |
- |
- |
- |
049 [1] 49 💬 |
275 |
Hydroxychloroquine |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
013 [23] 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
276 |
Hydroxychloroquine (z0188) |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
277 |
Hydroxychloroquine high |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
278 |
Hydroxychloroquine or chloroquine |
Chloroquine |
[4] D02125 D02125, D02366 D02366, D03469 D03469, D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
279 |
Hydroxychloroquine reduced |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
280 |
Ianalumab |
- |
- |
- |
- |
035 [5] 35, 46, 49, 53, 95 💬 |
281 |
Ibandronate |
Ibandronate |
[1] D08056 D08056 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
046 [2] 46, 49 💬 |
282 |
Ibandronate+alfacalcidol+calcium |
Alfacalcidol |
[2] D01518 D01518, D08056 D08056 💬 |
FDPS [2] FDPS, VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [8] Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis |
049 [1] 49 💬 |
283 |
Ici 182,780 (faslodex) |
- |
- |
- |
- |
049 [1] 49 💬 |
284 |
Icp-022 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
285 |
Ifn-a 2b kinoid drug substance |
- |
- |
- |
- |
049 [1] 49 💬 |
286 |
Ifn-a2b kinoid |
- |
- |
- |
- |
049 [1] 49 💬 |
287 |
Ifn-k |
- |
- |
- |
- |
049 [2] 49, 50 💬 |
288 |
Ifn-kinoid |
- |
- |
- |
- |
049 [2] 49, 50 💬 |
289 |
Ifn-kinoid drug substance |
- |
- |
- |
- |
049 [2] 49, 50 💬 |
290 |
Ifna-kinoid |
- |
- |
- |
- |
049 [2] 49, 50 💬 |
291 |
Il-2 |
Human interleukin-2 |
- |
- |
- |
002 [6] 2 , 46, 49, 53, 56, 96 💬 |
292 |
Il-6r nanobody |
- |
- |
- |
- |
049 [1] 49 💬 |
293 |
Ilt-101 |
- |
- |
- |
- |
049 [1] 49 💬 |
294 |
Immu-103 |
- |
- |
- |
- |
049 [1] 49 💬 |
295 |
Immune ablation and hematopoietic stem cell support. |
- |
- |
- |
- |
049 [1] 49 💬 |
296 |
Immunoglobulin g |
- |
- |
- |
- |
011 [7] 11, 13, 14, 49, 50, 63, 65 💬 |
297 |
Immunoglobulin g1, anti-(human type i interferon receptor) (human monoclonal medi-546 heavy chain), disulfide with human monoclonal medi-546-chain, dimer |
- |
- |
- |
- |
049 [1] 49 💬 |
298 |
Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate) |
Azathioprine |
[8] D00142 D00142, D00238 D00238, D00752 D00752, D02115 D02115, D03033 D03033, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
DHFR [4] DHFR, DHFR2, IMPDH1, IMPDH2 💬 |
Antifolate resistance [7] Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Purine metabolism |
049 [1] 49 💬 |
299 |
Individualized dose of rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
049 [1] 49 💬 |
300 |
Infliximab |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 [24] 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬 |
301 |
Influenz virus surface antigens |
- |
- |
- |
- |
049 [1] 49 💬 |
302 |
Influenza vaccine (surface antigen, inactivated) |
- |
- |
- |
- |
049 [1] 49 💬 |
303 |
Influvac |
- |
- |
- |
- |
046 [3] 46, 49, 50 💬 |
304 |
Interleukin 2 |
- |
- |
- |
- |
046 [9] 46, 49, 51, 56, 63, 95, 96, 97, 271 💬 |
305 |
Interleukin-2 |
Human interleukin-2 |
- |
- |
- |
002 [8] 2 , 35, 49, 55, 65, 96, 97, 162 💬 |
306 |
Intravenous immunoglobulin |
- |
- |
- |
- |
013 [8] 13, 14, 35, 38, 39, 49, 51, 309 💬 |
307 |
Ipp - 201101 |
- |
- |
- |
- |
049 [1] 49 💬 |
308 |
Ipp-201101 |
- |
- |
- |
- |
049 [1] 49 💬 |
309 |
Ipp-201101, p140 |
- |
- |
- |
- |
049 [1] 49 💬 |
310 |
Iscalimab |
Iscalimab |
[1] D11610 D11610 💬 |
CD40 [1] CD40 💬 |
Allograft rejection [16] Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis |
049 [2] 49, 53 💬 |
311 |
Itolizumab |
Itolizumab |
- |
- |
- |
049 [1] 49 💬 |
312 |
Itolizumab [bmab 600] |
Itolizumab |
- |
- |
- |
049 [1] 49 💬 |
313 |
Jbt-101 |
- |
- |
- |
- |
049 [4] 49, 50, 51, 299 💬 |
314 |
Jnj-55920839 |
- |
- |
- |
- |
049 [1] 49 💬 |
315 |
Jnj-56022473 |
- |
- |
- |
- |
049 [1] 49 💬 |
316 |
Kineret |
- |
- |
- |
- |
028 [9] 28, 41, 46, 49, 65, 106, 107, 266, 299 💬 |
317 |
Kpg-818 |
- |
- |
- |
- |
049 [1] 49 💬 |
318 |
Kzr-616 |
KZR-616 |
- |
- |
- |
049 [3] 49, 50, 61 💬 |
319 |
L04aa26 |
- |
- |
- |
- |
049 [1] 49 💬 |
320 |
La294 |
- |
- |
- |
- |
049 [1] 49 💬 |
321 |
Laquinimod |
Laquinimod |
- |
- |
- |
008 [4] 8 , 13, 49, 96 💬 |
322 |
Leflunomide |
Leflunomide |
[1] D00749 D00749 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
011 [10] 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 💬 |
323 |
Lenalidomide |
Lenalidomide |
[1] D04687 D04687 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
016 [7] 16, 26, 28, 34, 49, 284, 300 💬 |
324 |
Levothyroxine |
Levothyroxine |
[2] D01010 D01010, D08125 D08125 💬 |
THRA [2] THRA, THRB 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
049 [2] 49, 78 💬 |
325 |
Lisinopril |
Lisinopril |
[2] D00362 D00362, D08131 D08131 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 [7] 19, 46, 49, 66, 67, 113, 222 💬 |
326 |
Lisinopril pills |
Lisinopril |
[2] D00362 D00362, D08131 D08131 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
049 [1] 49 💬 |
327 |
Ljp 394 |
- |
- |
- |
- |
049 [1] 49 💬 |
328 |
Ljp394 |
- |
- |
- |
- |
049 [1] 49 💬 |
329 |
Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol) |
Acetate |
[11] D00105 D00105, D00182 D00182, D00554 D00554, D00953 D00953, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [3] ESR1, ESR2, PGR 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
046 [2] 46, 49 💬 |
330 |
Low dietary sodium |
- |
- |
- |
- |
049 [1] 49 💬 |
331 |
Low dose mesenchymal stem cells (mscs) |
- |
- |
- |
- |
049 [1] 49 💬 |
332 |
Low-dose aldesleukin (proleukin®) |
Aldesleukin |
[1] D00748 D00748 💬 |
IL2RA [3] IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction [14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 [1] 49 💬 |
333 |
Lulizumab pegol |
Lulizumab pegol |
- |
- |
- |
049 [1] 49 💬 |
334 |
Lupuzor |
- |
- |
- |
- |
049 [1] 49 💬 |
335 |
Ly2127399 |
- |
- |
- |
- |
013 [3] 13, 46, 49 💬 |
336 |
Ly3009104 |
- |
- |
- |
- |
046 [6] 46, 49, 50, 93, 107, 325 💬 |
337 |
Ly3361237 |
- |
- |
- |
- |
049 [1] 49 💬 |
338 |
Ly3471851 |
- |
- |
- |
- |
049 [1] 49 💬 |
339 |
Lymphostat-b |
- |
- |
- |
- |
049 [1] 49 💬 |
340 |
Lymphostat-b tm |
- |
- |
- |
- |
049 [1] 49 💬 |
341 |
Lymphostat-b®, monoclonal anti-blys, lsb, benlysta® |
- |
- |
- |
- |
049 [1] 49 💬 |
342 |
M2951 |
- |
- |
- |
- |
013 [3] 13, 46, 49 💬 |
343 |
M2951 (other name: evobrutinib) |
Evobrutinib |
- |
- |
- |
049 [1] 49 💬 |
344 |
M5049 |
- |
- |
- |
- |
049 [1] 49 💬 |
345 |
Mabthera |
- |
- |
- |
- |
011 [22] 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
346 |
Mabthera (rituximab) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [4] 13, 46, 49, 53 💬 |
347 |
Medi 545 |
- |
- |
- |
- |
049 [1] 49 💬 |
348 |
Medi-545 |
- |
- |
- |
- |
049 [2] 49, 50 💬 |
349 |
Medi-545 600 |
- |
- |
- |
- |
049 [1] 49 💬 |
350 |
Medi-546 |
- |
- |
- |
- |
049 [2] 49, 51 💬 |
351 |
Medi-570 0.03 mg |
- |
- |
- |
- |
049 [1] 49 💬 |
352 |
Medi-570 0.1 mg |
- |
- |
- |
- |
049 [1] 49 💬 |
353 |
Medi-570 0.3 mg |
- |
- |
- |
- |
049 [1] 49 💬 |
354 |
Medi-570 1 mg |
- |
- |
- |
- |
049 [1] 49 💬 |
355 |
Medroxyprogesterone |
- |
- |
- |
- |
049 [1] 49 💬 |
356 |
Melatonin |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
006 [11] 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
357 |
Meloxicam |
Meloxicam |
[1] D00969 D00969 💬 |
PTGS2 [1] PTGS2 💬 |
Alzheimer disease [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [4] 46, 49, 271, 296 💬 |
358 |
Memantine |
Memantine |
[2] D04905 D04905, D08174 D08174 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [7] 2 , 6 , 8 , 13, 49, 127, 205 💬 |
359 |
Mesenchymal stem cells |
- |
- |
- |
- |
002 [11] 2 , 6 , 13, 20, 49, 51, 60, 96, 222, 274, 299 💬 |
360 |
Mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
002 [9] 2 , 36, 49, 51, 60, 96, 97, 274, 284 💬 |
361 |
Mesna |
- |
- |
- |
- |
011 [11] 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬 |
362 |
Metformin |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 [21] 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
363 |
Methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 [35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
364 |
Methotrexate and folic acid |
Folic acid |
[3] D00070 D00070, D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
049 [1] 49 💬 |
365 |
Methyl prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
043 [3] 43, 49, 96 💬 |
366 |
Methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
367 |
Methylprednisolone sodium succinate |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [6] 13, 46, 49, 50, 51, 211 💬 |
368 |
Micofenolico acido |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
049 [1] 49 💬 |
369 |
Milatuzumab |
Milatuzumab |
[1] D08944 D08944 💬 |
CD74 [1] CD74 💬 |
Antigen processing and presentation [3] Antigen processing and presentation, Herpes simplex virus 1 infection, Tuberculosis |
049 [1] 49 💬 |
370 |
Milnacipran |
Milnacipran |
[1] D08222 D08222 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
046 [2] 46, 49 💬 |
371 |
Mizoribine |
Mizoribine |
[1] D01392 D01392 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
046 [8] 46, 49, 51, 53, 66, 94, 222, 224 💬 |
372 |
Mmf |
- |
- |
- |
- |
013 [13] 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬 |
373 |
Modafinil |
Modafinil |
[1] D01832 D01832 💬 |
- |
- |
006 [4] 6 , 13, 49, 93 💬 |
374 |
Monitor |
Methamidophos |
- |
- |
- |
002 [18] 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
375 |
Moxifloxacin |
Moxifloxacin |
[2] D00874 D00874, D08237 D08237 💬 |
- |
- |
002 [8] 2 , 6 , 46, 49, 85, 86, 240, 299 💬 |
376 |
Mpa |
- |
- |
- |
- |
049 [3] 49, 51, 60 💬 |
377 |
Mra 003 us |
- |
- |
- |
- |
049 [1] 49 💬 |
378 |
Msc treatment |
- |
- |
- |
- |
049 [1] 49 💬 |
379 |
Msc2364447c |
- |
- |
- |
- |
013 [2] 13, 49 💬 |
380 |
Mt-1303 high dose |
- |
- |
- |
- |
049 [1] 49 💬 |
381 |
Mt-1303 low dose |
- |
- |
- |
- |
049 [1] 49 💬 |
382 |
Mtx |
- |
- |
- |
- |
035 [12] 35, 40, 46, 49, 50, 60, 84, 96, 97, 107, 162, 271 💬 |
383 |
Multivitamin |
- |
- |
- |
- |
049 [1] 49 💬 |
384 |
Mycophenolate |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [34] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
385 |
Mycophenolate mofetil |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [32] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
386 |
Mycophenolate mofetil (mmf) |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
013 [7] 13, 49, 51, 60, 65, 66, 222 💬 |
387 |
Mycophenolate motetil |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
049 [1] 49 💬 |
388 |
Mycophenolic acid |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 [8] 11, 43, 49, 51, 60, 66, 96, 222 💬 |
389 |
Myfortic |
- |
- |
- |
- |
049 [5] 49, 66, 162, 222, 228 💬 |
390 |
Myfortic*50cpr riv 360mg |
- |
- |
- |
- |
049 [1] 49 💬 |
391 |
N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide |
- |
- |
- |
- |
049 [1] 49 💬 |
392 |
N-acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [10] 6 , 13, 19, 20, 49, 58, 85, 111, 164, 299 💬 |
393 |
Nelfinavir |
Nelfinavir |
[2] D00899 D00899, D08259 D08259 💬 |
- |
- |
049 [3] 49, 265, 331 💬 |
394 |
Nicotinamide |
Nicotinamide |
[1] D00036 D00036 💬 |
- |
- |
002 [6] 2 , 6 , 18, 49, 162, 191 💬 |
395 |
Nivolumab |
Nivolumab |
[1] D10316 D10316 💬 |
PDCD1 [1] PDCD1 💬 |
Cell adhesion molecules [3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 [12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
396 |
Nnc 0151-0000-0000 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
397 |
Nnc0114-0006 |
- |
- |
- |
- |
046 [3] 46, 49, 96 💬 |
398 |
Norethindrone |
Norethisterone |
[2] D00182 D00182, D00953 D00953 💬 |
PGR [1] PGR 💬 |
Breast cancer [4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 [4] 13, 46, 49, 299 💬 |
399 |
Normal saline |
- |
- |
- |
- |
006 [16] 6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬 |
400 |
Nox-e36 |
- |
- |
- |
- |
049 [1] 49 💬 |
401 |
Null |
- |
- |
- |
- |
006 [16] 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
402 |
Ocrelizumab |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [3] 13, 46, 49 💬 |
403 |
Olive |
Olea europaea leaf |
- |
- |
- |
013 [3] 13, 49, 53 💬 |
404 |
Olive oil |
Olea europaea leaf |
[1] D03311 D03311 💬 |
- |
- |
013 [3] 13, 49, 53 💬 |
405 |
Olumiant |
- |
- |
- |
- |
046 [4] 46, 49, 93, 107 💬 |
406 |
Omacor |
- |
- |
- |
- |
049 [1] 49 💬 |
407 |
Omega-3 |
Omega-3 fatty acids |
- |
- |
- |
013 [7] 13, 46, 49, 66, 79, 96, 299 💬 |
408 |
Oral prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [2] 49, 145 💬 |
409 |
Oral prednisone 5mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
410 |
Orencia |
- |
- |
- |
- |
044 [13] 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬 |
411 |
Orencia 125 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 [3] 46, 49, 53 💬 |
412 |
Ortho-novum |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
413 |
Ortho-novum 777 |
- |
- |
- |
- |
049 [1] 49 💬 |
414 |
Other: blood drawing only group c |
- |
- |
- |
- |
049 [1] 49 💬 |
415 |
Other: coaching sessions |
- |
- |
- |
- |
049 [1] 49 💬 |
416 |
Other: concomitant medication |
- |
- |
- |
- |
049 [1] 49 💬 |
417 |
Other: corn starch |
Starch, corn |
[1] D05297 D05297 💬 |
- |
- |
049 [1] 49 💬 |
418 |
Other: drug free |
- |
- |
- |
- |
049 [1] 49 💬 |
419 |
Other: fitbit activity monitor |
Methamidophos |
- |
- |
- |
049 [1] 49 💬 |
420 |
Other: group b sle one blood donation |
- |
- |
- |
- |
049 [1] 49 💬 |
421 |
Other: gsk2586184 single dose taken with food |
- |
- |
- |
- |
049 [1] 49 💬 |
422 |
Other: gsk2586184 single dose taken without food |
- |
- |
- |
- |
049 [1] 49 💬 |
423 |
Other: immunologic technique |
- |
- |
- |
- |
049 [1] 49 💬 |
424 |
Other: isa 51 vg |
- |
- |
- |
- |
049 [1] 49 💬 |
425 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 [21] 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
426 |
Other: pharmacokinetic analysis |
- |
- |
- |
- |
049 [1] 49 💬 |
427 |
Other: sle treatment |
- |
- |
- |
- |
049 [1] 49 💬 |
428 |
Other: smartphone application |
- |
- |
- |
- |
049 [1] 49 💬 |
429 |
Other: standard of care |
- |
- |
- |
- |
013 [7] 13, 49, 64, 85, 96, 245, 246 💬 |
430 |
Other: standard therapy |
- |
- |
- |
- |
049 [1] 49 💬 |
431 |
Other: standard treatment according to the clinical protocols |
- |
- |
- |
- |
049 [1] 49 💬 |
432 |
Other: ultrasonography assessment |
- |
- |
- |
- |
049 [1] 49 💬 |
433 |
Oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
434 |
Ozone |
Ozone |
- |
- |
- |
049 [2] 49, 51 💬 |
435 |
P 140 |
- |
- |
- |
- |
049 [1] 49 💬 |
436 |
Pah |
- |
- |
- |
- |
049 [3] 49, 53, 86 💬 |
437 |
Paquinimod |
Paquinimod |
- |
- |
- |
049 [2] 49, 51 💬 |
438 |
Paquinimod (abr-215757) |
Paquinimod |
- |
- |
- |
049 [1] 49 💬 |
439 |
Pf-04236921 |
- |
- |
- |
- |
049 [2] 49, 96 💬 |
440 |
Pf-06700841 |
PF-06700841 |
- |
- |
- |
049 [3] 49, 96, 97 💬 |
441 |
Pf-06700841 15 mg |
PF-06700841 |
- |
- |
- |
049 [1] 49 💬 |
442 |
Pf-06700841 25mg |
PF-06700841 |
- |
- |
- |
049 [1] 49 💬 |
443 |
Pf-06700841 30 mg |
PF-06700841 |
- |
- |
- |
049 [1] 49 💬 |
444 |
Pf-06700841 45 mg |
PF-06700841 |
- |
- |
- |
049 [1] 49 💬 |
445 |
Pf-06700841 5mg |
PF-06700841 |
- |
- |
- |
049 [1] 49 💬 |
446 |
Pf-06700841-15 |
PF-06700841 |
- |
- |
- |
049 [3] 49, 96, 97 💬 |
447 |
Pf-06835375 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
448 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 [30] 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
449 |
Phosphate-buffered saline |
Phosphate ion |
- |
- |
- |
049 [1] 49 💬 |
450 |
Pioglitazone |
Pioglitazone |
[2] D00945 D00945, D08378 D08378 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
451 |
Pitavastatin |
Pitavastatin |
[1] D01862 D01862 💬 |
- |
- |
049 [1] 49 💬 |
452 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
453 |
Plaquenil |
- |
- |
- |
- |
046 [4] 46, 49, 53, 96 💬 |
454 |
Pneumovax |
- |
- |
- |
- |
046 [3] 46, 49, 96 💬 |
455 |
Pooled mesenchymal stem cell |
- |
- |
- |
- |
049 [1] 49 💬 |
456 |
Prasterone |
Prasterone |
[1] D08409 D08409 💬 |
AR [3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 [1] 49 💬 |
457 |
Prasterone (gl701) |
Prasterone |
[1] D08409 D08409 💬 |
AR [3] AR, ESR1, ESR2 💬 |
Breast cancer [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 [1] 49 💬 |
458 |
Pravastatin |
Pravastatin |
[2] D00893 D00893, D08410 D08410 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬 |
459 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
460 |
Prednisolone/prednisone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
461 |
Prednisona |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [3] 46, 49, 222 💬 |
462 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
463 |
Prednisone acetate |
Acetate |
[2] D00473 D00473, D08416 D08416 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
040 [3] 40, 49, 224 💬 |
464 |
Prednisone discontinuation |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
465 |
Premarin and provera |
- |
- |
- |
- |
049 [1] 49 💬 |
466 |
Prevenar® and pneumo23® |
- |
- |
- |
- |
049 [1] 49 💬 |
467 |
Procedure: autologous cd34+hpc transplantation (hsct) |
- |
- |
- |
- |
049 [1] 49 💬 |
468 |
Procedure: autologous hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 [6] 11, 13, 14, 28, 49, 51 💬 |
469 |
Procedure: autologous peripheral blood stem cell transplantation |
- |
- |
- |
- |
028 [8] 28, 40, 41, 42, 45, 46, 49, 283 💬 |
470 |
Procedure: cd34+ peripheral blood stem cell reinfusion |
- |
- |
- |
- |
049 [1] 49 💬 |
471 |
Procedure: computed tomography |
- |
- |
- |
- |
034 [5] 34, 40, 46, 49, 96 💬 |
472 |
Procedure: leukapheresis |
- |
- |
- |
- |
049 [5] 49, 51, 96, 284, 285 💬 |
473 |
Procedure: mri, venipuncture |
- |
- |
- |
- |
049 [1] 49 💬 |
474 |
Procedure: non-myeloablative high dose immunosuppressive therapy conditioning (hdit) |
- |
- |
- |
- |
049 [1] 49 💬 |
475 |
Procedure: plasmapheresis |
- |
- |
- |
- |
011 [3] 11, 49, 222 💬 |
476 |
Procedure: positron emission tomography |
- |
- |
- |
- |
040 [4] 40, 46, 49, 96 💬 |
477 |
Procedure: reduced intensity allogeneic transplant |
- |
- |
- |
- |
049 [2] 49, 51 💬 |
478 |
Proleukin |
- |
- |
- |
- |
002 [3] 2 , 49, 65 💬 |
479 |
Quinipril |
- |
- |
- |
- |
049 [1] 49 💬 |
480 |
R-salbutamol |
Levosalbutamol |
[2] D02147 D02147, D08124 D08124 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 [1] 49 💬 |
481 |
R-salbutamol sulphate |
Levosalbutamol |
[2] D02147 D02147, D08124 D08124 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 [1] 49 💬 |
482 |
R932333 |
- |
- |
- |
- |
049 [1] 49 💬 |
483 |
Rabbit |
Rabbit |
- |
- |
- |
011 [8] 11, 13, 49, 51, 60, 65, 96, 285 💬 |
484 |
Rabbit anti-thymocyte globulin |
Rabbit |
- |
- |
- |
049 [2] 49, 65 💬 |
485 |
Rabbit antithymocyte globulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
049 [3] 49, 60, 96 💬 |
486 |
Radiation: fluorine f 18 clofarabine |
Clofarabine |
[1] D03546 D03546 💬 |
POLA1 [3] POLA1, POLA2, RRM1 💬 |
DNA replication [6] DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
040 [4] 40, 46, 49, 96 💬 |
487 |
Radiation: total body irradiation |
- |
- |
- |
- |
036 [7] 36, 49, 51, 60, 65, 283, 284 💬 |
488 |
Ramipril |
Ramipril |
[1] D00421 D00421 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
046 [7] 46, 49, 66, 67, 113, 218, 257 💬 |
489 |
Rankl/opg ratio |
- |
- |
- |
- |
049 [1] 49 💬 |
490 |
Rapamycin |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 [18] 2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬 |
491 |
Raptiva |
- |
- |
- |
- |
011 [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
492 |
Rayos |
- |
- |
- |
- |
049 [1] 49 💬 |
493 |
Rc18 160 mg plus standard therapy |
- |
- |
- |
- |
049 [1] 49 💬 |
494 |
Rc18 240 mg plus standard therapy |
- |
- |
- |
- |
049 [1] 49 💬 |
495 |
Rc18 80 mg plus standard therapy |
- |
- |
- |
- |
049 [1] 49 💬 |
496 |
Recombinant factor fc fusion protein |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
497 |
Recombinant zoster vaccine |
- |
- |
- |
- |
049 [1] 49 💬 |
498 |
Remicade |
- |
- |
- |
- |
040 [9] 40, 46, 49, 56, 84, 85, 96, 97, 271 💬 |
499 |
Rhumab 2h7 |
- |
- |
- |
- |
013 [3] 13, 46, 49 💬 |
500 |
Rhumab ifnalpha |
- |
- |
- |
- |
049 [1] 49 💬 |
501 |
Rigerimod |
- |
- |
- |
- |
049 [1] 49 💬 |
502 |
Riquent |
- |
- |
- |
- |
049 [1] 49 💬 |
503 |
Rituxan (rituximab) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
049 [1] 49 💬 |
504 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
505 |
Rivaroxaban |
Rivaroxaban |
[1] D07086 D07086 💬 |
F10 [1] F10 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
046 [5] 46, 49, 75, 91, 210 💬 |
506 |
Ro 106-1443 |
- |
- |
- |
- |
049 [1] 49 💬 |
507 |
Ro 496-4913 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
508 |
Ro7010939/f13 |
- |
- |
- |
- |
049 [1] 49 💬 |
509 |
Rontalizumab |
Rontalizumab |
[1] D09662 D09662 💬 |
IFNA1 [13] IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 |
Autoimmune thyroid disease [23] Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis |
049 [1] 49 💬 |
510 |
Rosuvastatin |
Rosuvastatin |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [11] 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
511 |
Rosuvastatin calcium |
Calcium |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
049 [4] 49, 79, 97, 299 💬 |
512 |
Royal jelly |
Royal jelly |
[1] D09754 D09754 💬 |
- |
- |
049 [1] 49 💬 |
513 |
Rslv-132 |
- |
- |
- |
- |
049 [2] 49, 53 💬 |
514 |
Salbutamol |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 [9] 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
515 |
Sar113244 |
- |
- |
- |
- |
049 [1] 49 💬 |
516 |
Sbi-087 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
517 |
Sc belimumab 200 mg |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
518 |
Sifalimumab |
Sifalimumab |
[1] D09668 D09668 💬 |
IFNA1 [13] IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 |
Autoimmune thyroid disease [23] Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis |
049 [1] 49 💬 |
519 |
Sifalimumab 1,200 mg |
Sifalimumab |
[1] D09668 D09668 💬 |
IFNA1 [13] IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 |
Autoimmune thyroid disease [23] Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis |
049 [1] 49 💬 |
520 |
Sifalimumab 200 mg |
Sifalimumab |
[1] D09668 D09668 💬 |
IFNA1 [13] IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 |
Autoimmune thyroid disease [23] Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis |
049 [1] 49 💬 |
521 |
Sifalimumab 600 mg |
Sifalimumab |
[1] D09668 D09668 💬 |
IFNA1 [13] IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 |
Autoimmune thyroid disease [23] Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis |
049 [1] 49 💬 |
522 |
Simvastatin |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [21] 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
523 |
Sirolimus |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 [35] 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
524 |
Sm101 |
- |
- |
- |
- |
049 [3] 49, 63, 66 💬 |
525 |
Sm934 |
- |
- |
- |
- |
049 [1] 49 💬 |
526 |
Solu-medrol |
- |
- |
- |
- |
013 [7] 13, 49, 50, 51, 53, 97, 211 💬 |
527 |
Soluble fc receptor |
- |
- |
- |
- |
049 [1] 49 💬 |
528 |
Soluble fc-gamma receptor iib |
- |
- |
- |
- |
049 [1] 49 💬 |
529 |
Sq fludarabine |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
049 [1] 49 💬 |
530 |
Standard dose of rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
049 [1] 49 💬 |
531 |
Standard of care |
- |
- |
- |
- |
006 [12] 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
532 |
Standard therapy |
- |
- |
- |
- |
049 [2] 49, 97 💬 |
533 |
Standard therapy (excluding immunosuppressants) |
- |
- |
- |
- |
049 [1] 49 💬 |
534 |
Standard therapy (including immunosuppressants) |
- |
- |
- |
- |
049 [1] 49 💬 |
535 |
Stelara |
- |
- |
- |
- |
049 [6] 49, 56, 96, 97, 269, 271 💬 |
536 |
Stelara® |
- |
- |
- |
- |
049 [3] 49, 96, 97 💬 |
537 |
Steroid drug |
- |
- |
- |
- |
049 [1] 49 💬 |
538 |
Steroid taper |
- |
- |
- |
- |
049 [1] 49 💬 |
539 |
Subcuvia |
- |
- |
- |
- |
014 [3] 14, 49, 65 💬 |
540 |
Sugar pill |
- |
- |
- |
- |
005 [8] 5 , 6 , 49, 67, 70, 86, 206, 210 💬 |
541 |
Sulfamethoxazole |
Sulfamethoxazole |
[1] D00447 D00447 💬 |
- |
- |
044 [4] 44, 49, 85, 299 💬 |
542 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 [25] 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
543 |
Switch to myfortic |
- |
- |
- |
- |
049 [1] 49 💬 |
544 |
Tab08 |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
545 |
Tabalumab |
Tabalumab |
[1] D10083 D10083 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 [2] 46, 49 💬 |
546 |
Tabalumab auto-injector |
Tabalumab |
[1] D10083 D10083 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 [2] 46, 49 💬 |
547 |
Tabalumab prefilled syringe |
Tabalumab |
[1] D10083 D10083 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 [2] 46, 49 💬 |
548 |
Taci-fc5 |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [3] 13, 46, 49 💬 |
549 |
Tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 [32] 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
550 |
Tak-079 |
- |
- |
- |
- |
011 [3] 11, 49, 63 💬 |
551 |
Thalidomide |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 [20] 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
552 |
The generic name is warfarin and many producers will be involved |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
049 [1] 49 💬 |
553 |
Tocopherol |
Tocopherol |
[1] D02332 D02332 💬 |
- |
- |
013 [5] 13, 49, 206, 257, 298 💬 |
554 |
Tocopherol acetate |
Acetate |
[1] D02332 D02332 💬 |
- |
- |
049 [1] 49 💬 |
555 |
Toctino |
- |
- |
- |
- |
049 [1] 49 💬 |
556 |
Toctino® |
- |
- |
- |
- |
049 [1] 49 💬 |
557 |
Tofacitinib |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 [12] 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
558 |
Tofacitinib citrate |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [5] 46, 49, 97, 107, 271 💬 |
559 |
Trade name xarelto |
- |
- |
- |
- |
049 [1] 49 💬 |
560 |
Trimethoprim |
Trimethoprim |
[2] D00145 D00145, D06236 D06236 💬 |
- |
- |
036 [6] 36, 44, 49, 60, 85, 299 💬 |
561 |
Trimethoprim-sulfamethoxazole |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
049 [2] 49, 299 💬 |
562 |
Triptorelin |
Triptorelin |
[1] D06247 D06247 💬 |
GNRHR [1] GNRHR 💬 |
GnRH signaling pathway [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction |
049 [2] 49, 76 💬 |
563 |
Triptorelin pamoate |
Triptorelin |
[1] D06247 D06247 💬 |
GNRHR [1] GNRHR 💬 |
GnRH signaling pathway [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction |
049 [1] 49 💬 |
564 |
Tru-015 |
TRU-015 |
- |
- |
- |
046 [3] 46, 49, 222 💬 |
565 |
Truxima |
- |
- |
- |
- |
049 [2] 49, 222 💬 |
566 |
Tv-4710 |
- |
- |
- |
- |
049 [1] 49 💬 |
567 |
Upadacitinib |
Upadacitinib |
[1] D10994 D10994 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
040 [7] 40, 41, 46, 49, 96, 97, 271 💬 |
568 |
Urine sample |
- |
- |
- |
- |
049 [3] 49, 51, 61 💬 |
569 |
Ustekinumab |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
037 [15] 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 |
570 |
Ustekinumab (approximately 6 mg/kg) |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 [1] 49 💬 |
571 |
Ustekinumab 90 mg |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 [4] 49, 50, 93, 96 💬 |
572 |
Ustekinumab 90 milligram (mg) |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 [1] 49 💬 |
573 |
Ustekinumab iv |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 [2] 49, 97 💬 |
574 |
Ustekinumab sc |
Ustekinumab |
[1] D09214 D09214 💬 |
IL12A [3] IL12A, IL12B, IL23A 💬 |
African trypanosomiasis [26] African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 [2] 49, 97 💬 |
575 |
Vaccination |
- |
- |
- |
- |
049 [1] 49 💬 |
576 |
Vaccine |
- |
- |
- |
- |
049 [1] 49 💬 |
577 |
Vay736 |
- |
- |
- |
- |
013 [7] 13, 35, 46, 49, 53, 85, 95 💬 |
578 |
Velcade |
- |
- |
- |
- |
011 [5] 11, 28, 46, 49, 61 💬 |
579 |
Velcade® |
- |
- |
- |
- |
011 [3] 11, 46, 49 💬 |
580 |
Versus hydroxychloroquine |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
581 |
Vib7734 |
- |
- |
- |
- |
049 [4] 49, 50, 51, 53 💬 |
582 |
Vip |
- |
- |
- |
- |
049 [3] 49, 51, 86 💬 |
583 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 [21] 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
584 |
Vitamin d 25(oh)d |
Vitamin D |
- |
- |
- |
049 [1] 49 💬 |
585 |
Vitamin d3 |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 [11] 6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬 |
586 |
Vitamin d3 400 iu |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
049 [1] 49 💬 |
587 |
Vitamin d3 6000 iu |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
049 [1] 49 💬 |
588 |
Vitamins: b6, b12, and folate |
Folic acid |
[1] D00070 D00070 💬 |
- |
- |
049 [1] 49 💬 |
589 |
Vobarilizumab |
Vobarilizumab |
[1] D11005 D11005 💬 |
- |
- |
049 [1] 49 💬 |
590 |
Warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 [11] 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
591 |
Warfarin sodium |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
049 [1] 49 💬 |
592 |
Xarelto |
- |
- |
- |
- |
049 [2] 49, 210 💬 |
593 |
Xmab5871 |
- |
- |
- |
- |
049 [2] 49, 300 💬 |
594 |
Zishenqing |
- |
- |
- |
- |
049 [1] 49 💬 |
595 |
Zostavax |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
596 |
Zostavax vaccine |
- |
- |
- |
- |
046 [2] 46, 49 💬 |